DeepMed Research

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

HCV Treatment Initiation During Acute Psychiatric Admission

Phase 4

Conditions: Hepatitis C

Interventions: Other: HCV care provided by hospitalist during acute psychiatric admission

First Posted Date: 2020-11-12

Last Posted Date: 2022-05-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 54

Registration Number: NCT04625322

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

Active, not recruiting

Conditions: Papillary Thyroid Cancer
Papillary Microcarcinoma of the Thyroid
Papillary Thyroid Carcinoma

First Posted Date: 2020-11-10

Last Posted Date: 2025-05-01

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 450

Registration Number: NCT04624477

Locations: 🇨🇦
University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada
🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada
🇨🇦
Nova Scotia Health, Halifax, Nova Scotia, Canada

and more 5 locations

Planned Semi-Elective Lung Tx Study

Not Applicable

Completed

Conditions: Lung Transplantation

Interventions: Procedure: Semi-Elective Lung Transplantation

First Posted Date: 2020-11-04

Last Posted Date: 2023-12-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 70

Registration Number: NCT04616365

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria
🇨🇦
University Health Network (Toronto General Hospital), Toronto, Ontario, Canada
🇪🇸
Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain

Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease

Phase 4

Conditions: Dry Eye Syndromes
Ocular Surface Disease

Interventions: Biological: Autologous platelet rich plasma eye drops

First Posted Date: 2020-10-29

Last Posted Date: 2020-10-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT04608084

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)

Completed

Conditions: HNSCC
Head and Neck Cancer
Squamous Cell Carcinoma
Advanced Cancer
Metastatic Cancer

First Posted Date: 2020-10-28

Last Posted Date: 2022-05-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 18

Registration Number: NCT04606940

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma

Active, not recruiting

Conditions: Head and Neck Cancer
Cancer
Head and Neck Squamous Cell Carcinoma

First Posted Date: 2020-10-22

Last Posted Date: 2024-05-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 35

Registration Number: NCT04599309

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Pilot Study

Not Applicable

Active, not recruiting

Conditions: Cardiotoxicity
Heart Failure
Cancer

Interventions: Behavioral: Cardio-oncology Rehabilitation (CORE)
Behavioral: Support

First Posted Date: 2020-10-22

Last Posted Date: 2024-06-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT04598646

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

COVID-19 Burnout Study

Not Applicable

Active, not recruiting

Conditions: Stress

Interventions: Behavioral: Mindfulness Based Intervention

First Posted Date: 2020-10-20

Last Posted Date: 2025-02-20

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 44

Registration Number: NCT04594278

Locations: 🇨🇦
University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)

Phase 3

Recruiting

Conditions: Bladder Cancer
Bladder Urothelial Carcinoma

Interventions: Drug: Gemcitabine
Drug: Cisplatin
Drug: Carboplatin

First Posted Date: 2020-10-05

Last Posted Date: 2024-03-12

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 14

Registration Number: NCT04574960

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

A Research Platform to Screen Healthcare Workers- Coordinated Approach to Pandemic Trials of COVID-19

Active, not recruiting

Conditions: Healthcare Worker
Covid19

Interventions: Diagnostic Test: Nasopharyngeal swab
Other: Questionnaire collection
Other: Optional blood completion
Other: Optional questionnaire completion

First Posted Date: 2020-10-05

Last Posted Date: 2024-02-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100000

Registration Number: NCT04574765

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy